ALC250117C50000
- 0.00
- 0.000.00%
Alcon Newsroom
$6.8 Bn Glaucoma 68-Market Analysis and Sales Forecasts 2023-2033 Featuring Abbvie, Allergan, Alcon, Pfizer, Merck, Santen, Ocular Therapeutix, PH Pharma, Nicox, DWTI, Thea Pharma, Betaliq, and Tarsier Pharma
Berenberg Bank Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $101.94
Berenberg Bank Reaffirms Their Buy Rating on Alcon (ALC)
Needham's Top Stocks for 2025: AX, CYBR, CART and More
Redburn Atlantic Upgrades Alcon(ALC.US) to Buy Rating, Raises Target Price to $102.3
Alcon Upgraded to Buy From Neutral at Redburn Atlantic
Stifel Maintains Alcon(ALC.US) With Buy Rating, Announces Target Price $100
Stifel Maintains Alcon(ALC.US) With Buy Rating
Stifel Nicolaus Remains a Buy on Alcon (ALC)
Ophthalmic Lasers Market Global Outlook & Forecast 2024-2029, With Key Vendor Profiles for Alcon, Bausch + Lomb, Johnson & Johnson, NIDEK and ZEISS - ResearchAndMarkets.com
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
Alcon Labs Recalls Systane Lubricant Eye Drops Over Fungal Contamination
Here's Why Alcon (ALC) Is a Strong Growth Stock
RxSight Cut to Hold at Stifel on Competition Concerns
UBS's Global Equity Focus List: Stocks Within Health Technology
UBS Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $105.57
This Is Why You Should Turn Defensive, Underweight Cyclicals – UBS
Alcon's Late-Stage Pipeline Set To Drive Revenue Growth Next Year -- Market Talk
Alcon Top Pick for 2025 at Needham, Added to Conviction List
Tesla To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Tuesday